Healthy Living/WellnessNovartis Odomzo Skin Cancer Drug Given FDA Nod Of Approval The FDA has approved a drug developed by Novartis for the treatment of the most common form of skin cancer. Odomzo was green-lighted for treatment of advanced basal cell carcinoma.by Rhodi Lee
Healthy Living/WellnessFDA's Proposal For New Food Label With More Detail On Added Sugar Meets Oppositionby Jim Algar
Healthy Living/WellnessFDA Approves Cholesterol-Lowering Drug Praluent By Regeneron And Sanofi: $15,000 A Year, Anyone?by Jill Arce
Healthy Living/WellnessFDA Wants Percent Daily Value For Added Sugar To Show On Nutrition Facts Labelby James Maynard
Healthy Living/WellnessSchizophrenia And Depression Drug Rexulti Gets FDA Nod Of Approvalby Dianne Depra
Healthy Living/WellnessMiami Blood Bank Closed By FDA Due To Numerous HIV-Related Violationsby Dianne Depra
Healthy Living/WellnessFDA Bolstering Warning Labels On Popular Painkillers: How Safe Are They Really?by James Maynard
Healthy Living/WellnessNew Study Reveals Why You Should Not Rely On Online Symptom Checkers: Yes, Dr. Internet Is No Goodby Sumit Passary
Healthy Living/WellnessFDA Extends Deadline For Chain Restaurants, Other Retail Establishments To Put Up Calorie Count In Menusby Jim Algar
Healthy Living/WellnessFDA Investigating Possible Risks Of Codeine In Cough Medicine For Childrenby Rina Marie Doctor